Xiankangda Life Sciences

Xiankangda Life Sciences is a Chinese biotechnology company dedicated to the development and clinical application of innovative cell therapies for regenerative medicine and immune-related disorders. Based in Shenzhen, the company operates specialized R&D platforms focusing on Mesenchymal Stem Cells (MSCs), Natural Killer (NK) cells, and induced Pluripotent Stem Cells (iPSCs). Their core technology, the "Super MSC" platform, aims to enhance the therapeutic efficacy of stem cells for treating conditions like knee osteoarthritis and chronic liver damage. Xiankangda maintains advanced GMP-compliant manufacturing facilities and engages in both investigator-initiated trials and formal clinical development. The company's mission is to provide high-quality, standardized cell products to address unmet medical needs in aging and chronic diseases.